TH-CAR-027 for Grade 4 Gliomas
NCT07384390
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
R/R Grade 4 Glioma
Interventions
DRUG:
TH-CART-027
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine